Sunday, December 22, 2024

Sunday, December 22, 2024

Organization Directory

Refine Your Search Big Business 3

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer's Disease
  2. 2 LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
  3. 3 PROVENTION BIO: Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
  4. 4 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
FDA Reporter